Please enter the email address you used to register, then we will send you a link to choose a new password
A total of 20 patients will be enrolled in the Phase 2a portion of the AvenActive Study which is designed to assess potential e...
COSCIENS Biopharma Inc. (NASDAQ:CSCI) (TSX:CSCI) ("COSCIENS" or the "Company"), a specialty biopharmaceutical c...